Yosuke Inagaki

Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells

Sho‐ichi Yamagishi, Yosuke Inagaki, Tamami Okamoto et al. · Journal of Biological Chemistry · 2002 · 311 citations · Full text

Medicine, Biochemistry, Cell Biology +17

Advanced Glycation End-Products Attenuate Human Mesenchymal Stem Cells and Prevent Cognate Differentiation Into Adipose Tissue, Cartilage, and Bone

Shinichiro Kume, Seiya Kato, Sho‐ichi Yamagishi et al. · Journal of Bone and Mineral Research · 2005 · 304 citations · Full text

Life Sciences, Cell Biology, Apoptosis +16

Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

Tamami Okamoto, Sho‐ichi Yamagishi, Yosuke Inagaki et al. · The FASEB Journal · 2002 · 256 citations

Life Sciences, Biochemistry, Molecular Biology +17

Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression

Sho‐ichi Yamagishi, Kazuo Nakamura, Takanori Matsui et al. · Journal of Biological Chemistry · 2006 · 218 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction

Kei Fukami, Seiji Ueda, Sho‐ichi Yamagishi et al. · Kidney International · 2004 · 217 citations · Full text

Life Sciences, Pharmacology, Cell Signaling +9